Intraprocedural yttrium-90 positron emission tomography/CT for treatment optimization of yttrium-90 radioembolization

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 2, 2014, Pages 271-275

  Bourgeois, Austin C ^a   Chang, Ted T ^a   Bradley, Yong C ^a   Acuff, Shelley N ^a   Pasciak, Alexander S ^a,b  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MACROSALB TC 99M; MICROSPHERE Y 90; RADIOACTIVE MICROSPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ADULT; ANGIOGRAPHY; ARTERY CATHETER; ARTIFICIAL EMBOLISM; CANCER PALLIATIVE THERAPY; CANCER STAGING; CASE REPORT; CELIAC ARTERY; COIL EMBOLIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; GASTRODUODENAL ARTERY; HEPATIC ARTERY; HEPATITIS C; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MICROCATHETER; MIDDLE AGED; MILD HEPATIC IMPAIRMENT; PET-CT SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE DISTRIBUTION; RADIOEMBOLIZATION; RADIOTHERAPY PLANNING SYSTEM; REVIEW; SOLUTION AND SOLUBILITY; TREATMENT PLANNING; TUMOR CLASSIFICATION; TUMOR VASCULARIZATION; TUMOR VOLUME;

(18)FDG; (90)Y; (99M)TC MAA; BODY SURFACE AREA; BSA; FLUORINE 18-LABELED DEOXYGLUCOSE; HCC; HEPATOCELLULAR CARCINOMA; T/N; TECHNETIUM-99M MACROAGGREGATED ALBUMIN; TTR; TUMOR-TO-NORMAL UPTAKE; TUMORICIDAL TARGET RATIO; YTTRIUM-90;

CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOGRAPHY, INTERVENTIONAL; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84893034568     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.11.004     Document Type: Article

References (16)

1. W. Dezarn, J.T. Cessna, and L.A. DeWerd et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies Med Phys 38 2011 4825 4845
2. S.A. Gulec, G. Mesoloras, W.A. Dezarn, P. McNeillie, and A. Kennedy Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to the liver flow ratio J Transl Med 5 2007 15 24
3. C. Chiesa, M. Maccauro, and R. Romito et al. Need feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with 90Y microspheres: the experience of the National Cancer Institute of Milan Q J Nucl Med Mol Imaging 55 2011 168 197
4. T.T. Chang, A.C. Bourgeois, A.M. Balius, and A.S. Pasciak Treatment modification of yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging J Vasc Interv Radiol 24 2013 333 337
5. A.S. Pasciak, and W.D. Erwin Effect of voxel size and computation method on Tc-99m MAA SPECT/CT-based dose estimation for Y-90 microsphere therapy IEEE Trans Med Imaging 28 2009 1754 1758
6. Y.H. Kao, J.D. Steinberg, and Y.-S. Tay et al. Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres EJNMMI Res 3 2013 1 12
7. A. Kennedy, S. Nag, and R. Salem et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the Radioembolization Brachytherapy Oncology Consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
8. R.L. Wahl, H. Jacene, Y. Kasamon, and M.A. Lodge From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med 50 2009 122S 150S
9. 90Y therapy of liver cancer Tech Cancer Res Treat 9 2010 253 261
10. M. Wondergem, M.L. Smits, and M. Elschot et al. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization J Nucl Med 54 2013 1294 1301
11. A. Kennedy, C Nutting, D Coldwell, J Gaiser, and C Drachenberg Pathologic response and microdosimetry of 90Y microspheres in man: review of four explanted whole livers Int J Radiat Oncol Biol Phys 60 2004 1552 1563
12. B. Atassi, A.K. Bangash, and A. Bahrani et al. Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay Radiographics 28 2008 81 99
13. A. Campbell, I. Bailey, and M. Burton Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy Phys Med Biol 46 2001 487 498
14. L. Strigari, R. Sciuto, and S. Rea et al. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIRSpheres: radiobiologic considerations J Nucl Med 51 2010 1377 1385
15. J.E. Dancey, F.A. Shepherd, and K. Paul et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres J Nucl Med 41 2000 1673 1681
16. V. Gates, A. Esmail, K. Marshall, S. Spies, and R. Salem Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept J Nucl Med 52 2011 72 76